The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson’s Disease

Levodopa (L-DOPA) treatment in Parkinson’s disease is limited by the emergence of L-DOPA-induced dyskinesia. Such dyskinesia is associated with aberrant gene regulation in neurons of the striatum, which is caused by abnormal dopamine release from serotonin terminals. Previous work showed that modula...

Descripción completa

Detalles Bibliográficos
Autores principales: Altwal, Feras, Moon, Connor, West, Anthony R., Steiner, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600385/
https://www.ncbi.nlm.nih.gov/pubmed/33050305
http://dx.doi.org/10.3390/cells9102265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600385/
https://www.ncbi.nlm.nih.gov/pubmed/33050305
http://dx.doi.org/10.3390/cells9102265

Ejemplares similares